Shingles vaccine connected to ‘exciting’ health benefits in large study

New research reveals the shingles vaccine may cut vascular dementia risk by half, offering unexpected brain protection beyond ...
The Malaysian Reserve

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn’s disease at two years

Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...
The Healthy @Reader's Digest on MSN

I’m 27 and Thought I Had Chronic Acne—Until a Doctor Explained My Condition Affects 3.5 Million Americans

A young woman shares her emotional 15-year journey with hidradenitis suppurativa, chronic skin inflammation for which ...